Publications by authors named "Peter Villiger"

Claim this Profile
E
Efficacy of tocilizumab monotherapy after ultrashort glucocorticoid administration to treat giant cell arteritis: three-year follow-up.
Lisa Christ, Luca Seitz, Godehard Scholz, Lukas Bütikofer, Florian Kollert, Peter M Villiger

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A glossary of signs and symptoms of giant cell arteritis.
Medha L Soowamber, Milena Bond, Zahi Touma, Carol Langford, Catalina Sanchez-Alvarez, Peter M Villiger

Ann Rheum Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumab.
Lisa Christ, Harald M Bonel, Jennifer L Cullmann, Luca Seitz, Lukas Bütikofer, Peter M Villiger

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica.
Pascal Seitz, Jennifer Cullmann, Susana Bucher, Lukas Bütikofer, Stephan Reichenbach, Peter M Villiger

Rheumatology (Oxford)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum protein profiling reveals distinct patient clusters in giant cell arteritis.
Flavia Zingg, Fabio S Ryser, Andrea D Gloor, Christos Polysopoulos, Peter M Villiger

Rheumatology (Oxford)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis.
Elisa Pesce, Mauro Bombaci, Stefania Croci, Martina Bonacini, Chiara Marvisi, Peter M Villiger

Clin Exp Rheumatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-B27, axial spondyloarthritis and survival.
Zhixiu Li, Mohammad Kazim Khan, Sjef M van der Linden, Bjorn Winkens, Peter M Villiger

Ann Rheum Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis.
Wolfgang A Schmidt, Bhaskar Dasgupta, Jennifer Sloane, Angeliki Giannelou, Yuqing Xu, Peter M Villiger

Arthritis Res Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial).
Lisa Christ, Andrea D Gloor, Florian Kollert, Timo Gaber, Frank Buttgereit, Peter M Villiger

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of giant-cell arteritis in Switzerland: an online national survey.
Michele Iudici, Andrea Katharina Hemmig, Mihaela Stegert, Delphine Sophie Courvoisier, Sabine Adler, Peter Villiger

Swiss Med Wkly· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.
Mathis Komminoth, Marc Y Donath, Matthias Hepprich, Philipp Schuetz, Claudine A Blum, Peter M Villiger

PLoS One· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11 International Conference on Reproduction, Pregnancy and Rheumatic Diseases.
Laura Andreoli, Cecilia B Chighizola, Luca Iaccarino, Angela Botta, Maria Gerosa, Peter Villiger

Autoimmun Rev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab and Aflibercept as a Treatment Option for Refractory Macular Edema after Acute Retinal Necrosis.
Alexandra Bograd, Peter M Villiger, Marion R Munk, Isabel Bolt, Christoph Tappeiner

Ocul Immunol Inflamm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Assessment Chronic Illness Care (PACIC) and its associations with quality of life among Swiss patients with systemic sclerosis: a mixed methods study.
Agnes Kocher, Michael Simon, Andrew A Dwyer, Catherine Blatter, Jasmina Bogdanovic, Peter M Villiger

Orphanet J Rare Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality in ankylosing spondylitis according to treatment: comment on the article by Ben Shabat et al.
Zhixiu Li, Mohammad K Khan, Peter M Villiger, Sjef van der Linden, Matthew A Brown

Arthritis Care Res (Hoboken)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy.
Andrea Amstad, Eleftherios Papagiannoulis, Almut Scherer, Andrea Rubbert-Roth, Axel Finckh, Peter M Villiger

Rheumatology (Oxford)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis.
Godehard A Scholz, Michaela Fux, Lisa Christ, Joseena Iype, Yara Banz, Peter M Villiger

J Autoimmun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls.
Johannes Mischlinger, Veronika K Jaeger, Adrian Ciurea, Cem Gabay, Paul Hasler, Peter Villiger

Vaccine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence of axial spondyloarthritis among first-degree relatives in a prospective 35-year-follow-up family study.
Sjef M van der Linden, Muhammad Asim Khan, Zhixiu Li, Heinz Baumberger, Hermine van Zandwijk, Peter M Villiger

RMD Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors predicting axial spondyloarthritis among first-degree relatives of probands with ankylosing spondylitis: a family study spanning 35 years.
Sjef M van der Linden, Muhammad Asim Khan, Zhixiu Li, Heinz Baumberger, Hermine van Zandwijk, Peter M Villiger

Ann Rheum Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.
Christophe Schmitt, Laura Brockwell, Mylène Giraudon, Mauro Zucchetto, Lisa Christ, Peter M Villiger

Arthritis Res Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter.
Zhixiu Li, Sjef M van der Linden, Muhammad Asim Khan, Heinz Baumberger, Hermine van Zandwijk, Peter M Villiger

RMD Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study.
Lisa Christ, Luca Seitz, Godehard Scholz, Adela-Cristina Sarbu, Jennifer Amsler, Peter M Villiger

Lancet Rheumatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and healthcare professional eHealth literacy and needs for systemic sclerosis support: a mixed methods study.
Agnes Kocher, Michael Simon, Andrew A Dwyer, Catherine Blatter, Jasmina Bogdanovic, Peter M Villiger

RMD Open· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model.
Agnes Kocher, Mwidimi Ndosi, Kris Denhaerynck, Michael Simon, Andrew A Dwyer, Peter M Villiger

Orphanet J Rare Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis